We’re sorry, our emails are down due to an outage. We’re still here for you: please phone our NET Nurse line on 1300 287 363. In an emergency, call 000.

13th INCA Global NET Patient Advocate Summit

This week our CEO Meredith Cummins, in her role as President Elect of the INCA Board of Directors and Chair of the Research Committee, presented at the 13th INCA Global NET Patient Advocate Summit in Bulgaria.

Meredith shared insights from Australia on: – Optimal Care Pathway & PCP Training – showing how ongoing promotion, patient involvement, and regular reviews ensure NET care stays current and effective. – AUSNET Nurse-led Shared Care & Gut Microbiome Study – highlighting how collaboration and research are deepening understanding of NETs and informing future care.

We were also proud to have NECA Board Member and Medical Oncologist Dr David Chan present at the Summit, contributing his expertise to the global conversation on NET Optimal Care Pathway and research. By sharing our experience with education modules, reviews and patient inclusion,

NECA continues to drive improvements in NET care, not only in Australia but across the global community.






Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

Racing for a Cure 2026 – thank you Rob!

NECA Joins Cancer Australia’s Low Survival Cancers Mission Roundtable

NECA CEO Meredith Cummins named Health and Social Services Government Relations Practitioner of the Year

The Faces of HTA Reform booklet is here

Neuroendocrine Cancer Day

Neuroendocrine Cancer Day is on 10 November, and every bit of support counts.

Create an event, share your artwork, or donate on our ‘Double Your Impact’ days. There are so many ways to stand with the NET community.